Your browser doesn't support javascript.
loading
RFC1 expansions are a common cause of idiopathic sensory neuropathy.
Currò, Riccardo; Salvalaggio, Alessandro; Tozza, Stefano; Gemelli, Chiara; Dominik, Natalia; Galassi Deforie, Valentina; Magrinelli, Francesca; Castellani, Francesca; Vegezzi, Elisa; Businaro, Pietro; Callegari, Ilaria; Pichiecchio, Anna; Cosentino, Giuseppe; Alfonsi, Enrico; Marchioni, Enrico; Colnaghi, Silvia; Gana, Simone; Valente, Enza Maria; Tassorelli, Cristina; Efthymiou, Stephanie; Facchini, Stefano; Carr, Aisling; Laura, Matilde; Rossor, Alexander M; Manji, Hadi; Lunn, Michael P; Pegoraro, Elena; Santoro, Lucio; Grandis, Marina; Bellone, Emilia; Beauchamp, Nicholas J; Hadjivassiliou, Marios; Kaski, Diego; Bronstein, Adolfo M; Houlden, Henry; Reilly, Mary M; Mandich, Paola; Schenone, Angelo; Manganelli, Fiore; Briani, Chiara; Cortese, Andrea.
Afiliación
  • Currò R; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Salvalaggio A; IRCCS Mondino Foundation, Pavia, Italy.
  • Tozza S; Department of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
  • Gemelli C; Department of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
  • Dominik N; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Galassi Deforie V; Neurology Unit, IRCCS San Martino Hospital, Genoa, Italy.
  • Magrinelli F; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Castellani F; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Vegezzi E; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Businaro P; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Callegari I; Department of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
  • Pichiecchio A; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Cosentino G; IRCCS Mondino Foundation, Pavia, Italy.
  • Alfonsi E; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Marchioni E; IRCCS Mondino Foundation, Pavia, Italy.
  • Colnaghi S; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Gana S; IRCCS Mondino Foundation, Pavia, Italy.
  • Valente EM; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Tassorelli C; IRCCS Mondino Foundation, Pavia, Italy.
  • Efthymiou S; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Facchini S; IRCCS Mondino Foundation, Pavia, Italy.
  • Carr A; IRCCS Mondino Foundation, Pavia, Italy.
  • Laura M; IRCCS Mondino Foundation, Pavia, Italy.
  • Rossor AM; IRCCS Mondino Foundation, Pavia, Italy.
  • Manji H; IRCCS Mondino Foundation, Pavia, Italy.
  • Lunn MP; IRCCS Mondino Foundation, Pavia, Italy.
  • Pegoraro E; Department of Molecular Medicine, Unit of Genetics, Università degli studi di Pavia, Pavia, Italy.
  • Santoro L; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Grandis M; IRCCS Mondino Foundation, Pavia, Italy.
  • Bellone E; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Beauchamp NJ; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Hadjivassiliou M; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Kaski D; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Bronstein AM; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Houlden H; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Reilly MM; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Mandich P; Department of Neurosciences, ERN Neuromuscular Unit, University of Padova, Padova, Italy.
  • Schenone A; Department of Neuroscience and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
  • Manganelli F; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • Briani C; Neurology Unit, IRCCS San Martino Hospital, Genoa, Italy.
  • Cortese A; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Brain ; 144(5): 1542-1550, 2021 06 22.
Article en En | MEDLINE | ID: mdl-33969391
ABSTRACT
After extensive evaluation, one-third of patients affected by polyneuropathy remain undiagnosed and are labelled as having chronic idiopathic axonal polyneuropathy, which refers to a sensory or sensory-motor, axonal, slowly progressive neuropathy of unknown origin. Since a sensory neuropathy/neuronopathy is identified in all patients with genetically confirmed RFC1 cerebellar ataxia, neuropathy, vestibular areflexia syndrome, we speculated that RFC1 expansions could underlie a fraction of idiopathic sensory neuropathies also diagnosed as chronic idiopathic axonal polyneuropathy. We retrospectively identified 225 patients diagnosed with chronic idiopathic axonal polyneuropathy (125 sensory neuropathy, 100 sensory-motor neuropathy) from our general neuropathy clinics in Italy and the UK. All patients underwent full neurological evaluation and a blood sample was collected for RFC1 testing. Biallelic RFC1 expansions were identified in 43 patients (34%) with sensory neuropathy and in none with sensory-motor neuropathy. Forty-two per cent of RFC1-positive patients had isolated sensory neuropathy or sensory neuropathy with chronic cough, while vestibular and/or cerebellar involvement, often subclinical, were identified at examination in 58%. Although the sensory ganglia are the primary pathological target of the disease, the sensory impairment was typically worse distally and symmetric, while gait and limb ataxia were absent in two-thirds of the cases. Sensory amplitudes were either globally absent (26%) or reduced in a length-dependent (30%) or non-length dependent pattern (44%). A quarter of RFC1-positive patients had previously received an alternative diagnosis, including Sjögren's syndrome, sensory chronic inflammatory demyelinating polyneuropathy and paraneoplastic neuropathy, while three cases had been treated with immune therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Polineuropatías / Proteína de Replicación C Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Asunto principal: Polineuropatías / Proteína de Replicación C Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Año: 2021 Tipo del documento: Article País de afiliación: Italia